The Future of Squamous Cell Lung Cancer Treatment

November 13, 2014
Peter Hammerman, MD, PhD

Special Reports, NSCLC (Issue 5), Volume 5, Issue 1

Peter Hammerman, MD, PhD, assistant professor of medicine, Harvard Medical School, Dana-Farber Cancer Institute, discusses the future treatment of squamous cell lung cancer.

Peter Hammerman, MD, PhD, assistant professor of medicine, Harvard Medical School, Dana-Farber Cancer Institute, discusses the future treatment of squamous cell lung cancer.

Learn more about the treatment of squamous cell lung cancer > >